| CAS NO: | 300553-18-8 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
AVX 001 (AVX-001; AKH-217; FP-025; AKH217; FP025; AVX001) is a small molecule compound that targets the group IVa phospholipase A2 (GIVaPLA2) enzyme and is being developed by Coegin Pharma (formerly Avexxin AS). AVX-001 is a cytosolic phospholipase A2 (cPLA2) inhibitor potentially for the treatment of psoriasis.
纯度：≥98%
CAS：300553-18-8
m.cnreagent.com